Skip to main content
CMS.gov Centers for Medicare & Medicaid Services CMS.gov Centers for Medicare & Medicaid Services opens in new window
CMS.gov Centers for Medicare & Medicaid Services
Centers for Medicare & Medicaid Services

Main header

  • About Us
  • Newsroom
  • Data & Research
Newsroom

Newsroom_Navigation

  • Press Kit
  • Data
  • Contact
  • Blog
  • Podcast

 

 

 

Press release

CMS Approves Washington State Plan Amendment Proposal to Allow Supplemental Rebates involving a “Subscription” Model for Prescription Drug Payment in Medicaid

Jun 12, 2019
  • Coverage
  • Medicaid & CHIP
  • Prescription drugs

Share

opens in new window opens in new window opens in new window

CMS Approves Washington State Plan Amendment Proposal to Allow Supplemental Rebates involving a “Subscription” Model for Prescription Drug Payment in Medicaid

Today, the Centers for Medicare & Medicaid Services (CMS) approved the fourth Medicaid state plan amendment proposal to negotiate supplemental rebate agreements involving value-based purchasing arrangements with drug manufacturers that allows states to link payment for prescription drugs to the value delivered.

This approval is for the state of Washington and follows similar approvals for proposals from Oklahoma, Michigan, and Colorado.  Washington’s proposal is specifically designed to allow the state to negotiate under a “subscription” model with manufacturers of prescription drugs that treat patients with the Hepatitis C Virus.

“High and rising prescription drug prices create major challenges, including for Medicaid agencies,” said CMS Administrator Seema Verma.  “Under President Trump’s leadership, CMS is strengthening the ability of states to negotiate with pharmaceutical companies to lower drug prices.  Washington State’s innovative proposal will demand value from pharmaceutical companies and take steps to eradicate the Hepatitis C virus in their state.  CMS is committed to increasing states’ flexibility to develop policies that lower costs, increase the predictability of expenses, and improve access for patients.”

Under Washington’s proposed subscription model, the state would pay a fixed annual amount to a pharmaceutical manufacturer to purchase an unrestricted supply of Hepatitis C drugs.  Today’s approval of a state plan amendment to pursue supplemental rebate agreements involving value-based purchasing is the first that CMS has approved that is primarily focused on Hepatitis C drugs.

CMS-authorized supplemental rebates that pharmaceutical companies pay to states are exempt from the Medicaid “Best Price” rule.  This rule requires prescription drug manufacturers to offer the lowest price for a drug they negotiate with any other purchaser (subject to certain exceptions) to all states in the Medicaid program.

The value-based supplemental rebate agreement template includes an approved framework for states to negotiate and enter into manufacturer-specific agreements and includes such parameters as the utilization period, outcome-based benchmarks, intervention population for which benchmarks will be measured, and evaluation methodology.  CMS welcomes proposals from other states for state plan amendments to allow negotiation of supplemental rebates involving value based purchasing in Medicaid, and the agency has heard additional interest in a “subscription” model for Hepatitis C drugs.

###

Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.

  • Previous
  • Next

Related Releases

  • Medicare Coverage of Innovative Technology (CMS-3372-F)
    Jan 12, 2021
  • CMS unleashes innovation to ensure our nation’s seniors have access to the latest advancements
    Jan 12, 2021
  • CMS Proposes Updates to Coverage Policy for Autologous Blood-Derived Products for Chronic Non-Healing Wounds
    Dec 21, 2020
  • CMS Updates Coverage Policies for Artificial Hearts and Ventricular Assist Devices (VADs)
    Dec 01, 2020
  • CMS Finalizes Policy that will Increase the Number of Available Lifesavings Organs by Holding Organ Procurement Organizations Accountable through Transparency and Competition
    Nov 20, 2020

Contact us

CMS News and Media Group
Catherine Howden, Director
Brian Leshak, Deputy Director
Jason Tross, Deputy Director

Media Inquiries Form
202-690-6145

Get email updates

Sign up to get the latest information about your choice of CMS topics in your inbox. Also, you can decide how often you want to get updates.

CMS & HHS WEBSITES

  • Medicare.govopens in new window
  • MyMedicare.govopens in new window
  • Medicaid.govopens in new window
  • InsureKidsNow.govopens in new window
  • HealthCare.govopens in new window
  • HHS.govopens in new window

HELPFUL LINKS

  • Acronyms
  • Archive
  • Contacts
  • Glossary
  • Privacy policy
  • Privacy settings

RSS FEEDS

  • Newsroom
  • Blog
  • Podcast
U.S. Department of Health & Human Servicesopens in new window Centers for Medicare & Medicaid Servicesopens in new window

A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services.

7500 Security Boulevard, Baltimore, MD 21244

opens in new window opens in new window opens in new window

TOOLS

  • Web policiesopens in new window
  • Plain languageopens in new window
  • No Fear Actopens in new window
  • Freedom of Information Actopens in new window
  • Inspector Generalopens in new window